Philip T. Ninan

13.6k citations

111 papers · 8.7k indexed · 3 hit papers · h-index 42

Biological Psychiatry top 0.2%
- Tryptophan and brain disorders 13
Experimental and Cognitive Psychology top 0.2%
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes 36
- Mental Health Research Topics 24
Pharmacology top 0.1%
- Treatment of Major Depression 51
Behavioral Neuroscience top 0.5%
Psychiatry and Mental health top 0.5%
- Electroconvulsive Therapy Studies 10
Clinical Psychology
- Obsessive-Compulsive Spectrum Disorders 16
- Child and Adolescent Psychosocial and Emotional Development 9
Cellular and Molecular Neuroscience
- Neurotransmitter Receptor Influence on Behavior 9

Co-authors: A. John Rush Susan G. Kornstein Michael E. Thase Madhukar H. Trivedi Martin B. Keller Daniel N. Klein James H. Kocsis John C. Markowitz
Cited by: Biological Psychiatry Experimental and Cognitive Psychology Pharmacology
Journals: Science (2 papers)Proceedings of the National Academy of Sciences (1 paper)Journal of Neuroscience (1 paper)
Partner nations: United States Germany Canada

In The Last Decade

Philip T. Ninan

102 papers receiving 8.3k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2006 Neuropsychopharmacology
2003 Proceedings of the National Academy of Sciences
2003 Biological Psychiatry

Peers

Countries citing papers authored by Philip T. Ninan

Since Specialization

Citations

This map shows the geographic impact of Philip T. Ninan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip T. Ninan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip T. Ninan more than expected).

Fields of papers citing papers by Philip T. Ninan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip T. Ninan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip T. Ninan. The network helps show where Philip T. Ninan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Philip T. Ninan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philip T. Ninan Line = papers co-authored together Philip T. Ninan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Sexual Functioning in Patients With Recurrent Major Depressive Disorder Enrolled in the PREVENT Study The Journal of Nervous and Mental Disease ·Alan J. Gelenberg,David L. Dünner,Anthony J. Rothschild,Ron Pedersen,Kathleen M. Dorries,Philip T. Ninan	2013	14
2	Recovery and subsequent recurrence in patients with recurrent major depressive disorder Journal of Psychiatric Research ·Boadie W. Dunlop,Peter Holland,Weihang Bao,Philip T. Ninan,Martin B. Keller	2012	13
3	Remission With Venlafaxine Extended Release or Selective Serotonin Reuptake Inhibitors in Depressed Patients The Primary Care Companion For CNS Disorders ·Michael E. Thase,Philip T. Ninan,Jeff Musgnung,Madhukar H. Trivedi	2011	11
4	Analysis of the Effect of Desvenlafaxine on Anxiety Symptoms Associated with Major Depressive Disorder: Pooled Data from 9 Short-Term, Double-blind, Placebo-Controlled Trials CNS Spectrums ·Karen A. Tourian,Qin Jiang,Philip T. Ninan	2010	15
5	Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder Journal of Psychiatric Research ·Boadie W. Dunlop,Thomas Li,Susan G. Kornstein,Edward S. Friedman,Anthony J. Rothschild,Ron Pedersen,Philip T. Ninan,Martín Keller,Madhukar H. Trivedi	2010	43
6	Desvenlafaxine and Weight Change in Major Depressive Disorder The Primary Care Companion to The Journal of Clinical Psychiatry ·Karen A. Tourian,Claire Leurent,Jay Graepel,Philip T. Ninan	2010	12
7	Differential effects of venlafaxine in the treatment of major depressive disorder according to baseline severity European Archives of Psychiatry and Clinical Neuroscience ·Andreas Schmitt,Michael Bauer,Hans‐Peter Volz,Hans‐Jürgen Mœller,Qin Jiang,Philip T. Ninan,Peter-Andreas Loeschmann	2009	22
8	A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression Journal of Psychiatric Research ·Gabor I. Keitner,Steven J. Garlow,Christine E. Ryan,Philip T. Ninan,David A. Solomon,Charles B. Nemeroff,Martin B. Keller	2008	75
9	Use of Dialectical Behavior Therapy in Borderline Personality Disorder: A View From Residency Academic Psychiatry ·Bhanu Sharma,Boadie W. Dunlop,Philip T. Ninan,Ronald H. Bradley	2007	8
10	Prevention of Recurrent Episodes of Depression With Venlafaxine ER in a 1-Year Maintenance Phase From the PREVENT Study The Journal of Clinical Psychiatry ·James H. Kocsis,Michael E. Thase,Madhukar H. Trivedi,Richard C. Shelton,Susan G. Kornstein,Charles B. Nemeroff,Edward S. Friedman,Alan J. Gelenberg,David L. Dünner,Robert M. A. Hirschfeld,Anthony J. Rothschild,James M. Ferguson,Alan F. Schatzberg,John Zajecka,Ronald Pedersen,Bing Chun Yan,Saeed Ahmed,Jeff Musgnung,Philip T. Ninan,Martín Keller	2007	46
11	Coadministration of Modafinil and a Selective Serotonin Reuptake Inhibitor From the Initiation of Treatment of Major Depressive Disorder With Fatigue and Sleepiness Journal of Clinical Psychopharmacology ·Boadie W. Dunlop,Paul Crits‐Christoph,Dwight L. Evans,Jack Hirschowitz,H. Brent Solvason,Karl Rickels,Steven J. Garlow,Robert Gallop,Philip T. Ninan	2007	41
12	Effects of 12 Months of Vagus Nerve Stimulation in Treatment-Resistant Depression: A Naturalistic Study Biological Psychiatry ·A. John Rush,Harold A. Sackeïm,Lauren B. Marangell,Mark S. George,Stephen K. Brannan,Sonia M. Davis,Phil Lavori,Robert H. Howland,Mitchel A. Kling,Barry R. Rittberg,Linda L. Carpenter,Philip T. Ninan,Francisco Moreno,Sonia Thomas,Charles R. Conway,Michael J. Burke,John J. Barry	2005	270
13	A One-Year Comparison of Vagus Nerve Stimulation with Treatment as Usual for Treatment-Resistant Depression Biological Psychiatry ·Mark S. George,A. John Rush,Lauren B. Marangell,Harold A. Sackeïm,Stephen K. Brannan,Sonia M. Davis,Robert H. Howland,Mitchel A. Kling,Francisco Moreno,Barry R. Rittberg,David L. Dünner,Sonia Thomas,Linda L. Carpenter,Michael J. Burke,Philip T. Ninan,Paul J. Goodnick	2005	254
14	The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depressionbreakdown → Biological Psychiatry ·A. John Rush,Madhukar H. Trivedi,Hicham M. Ibrahim,Thomas Carmody,Bruce A. Arnow,Daniel N. Klein,John C. Markowitz,Philip T. Ninan,Susan G. Kornstein,Rachel Manber,Michael E. Thase,James H. Kocsis,Martin B. Keller	2003	2955
15	A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Controlled-Release Fluvoxamine in Patients With Obsessive-Compulsive Disorder The Journal of Clinical Psychiatry ·Eric Hollander,(unknown),Wayne K. Goodman,John H. Greist,Philip T. Ninan,Haichen Yang,David Li,Luigi Barbato	2003	74
16	Introduction: Generalized Anxiety Disorder: Why Are We Failing Our Patients? The Journal of Clinical Psychiatry ·Philip T. Ninan	2001	5
17	Symptomatic and syndromal anxiety and depression Depression and Anxiety ·Philip T. Ninan,Joseph R. Berger	2001	35
18	Insight and treatment outcome in obsessive-compulsive disorder Comprehensive Psychiatry ·Jonathan A. Eisen,Steven A. Rasmussen,Katharine A. Phillips,Lawrence H. Price,Jonathan Davidson,R. Bruce Lydiard,Philip T. Ninan,Teresa A. Piggott	2001	120
19	Use of venlafaxine other psychiatric disorders Depression and Anxiety ·Philip T. Ninan	2000	11
20	Venlafaxine: A novel antidepressant that has a dual mechanism of action PubMed ·James Andrews,Philip T. Ninan,Charles B. Nemeroff	1996	70

About Philip T. Ninan

Philip T. Ninan is a scholar working on Biological Psychiatry, Experimental and Cognitive Psychology and Pharmacology, having authored 111 papers that have together received 8.7k indexed citations. Recurring topics across this work include Treatment of Major Depression (51 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (36 papers), Mental Health Research Topics (24 papers), Obsessive-Compulsive Spectrum Disorders (16 papers), Tryptophan and brain disorders (13 papers), Electroconvulsive Therapy Studies (10 papers), Child and Adolescent Psychosocial and Emotional Development (9 papers) and Neurotransmitter Receptor Influence on Behavior (9 papers). The work is most often cited by research in Biological Psychiatry (1.1k citations), Experimental and Cognitive Psychology (2.7k citations) and Pharmacology (2.8k citations). Philip T. Ninan has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include A. John Rush, Susan G. Kornstein, Michael E. Thase, Madhukar H. Trivedi, Martin B. Keller, Daniel N. Klein, James H. Kocsis, John C. Markowitz, Rachel Manber and Bruce A. Arnow. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact